Literature DB >> 21210289

Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis.

Cesar Ramos-Remus1, Guillermo Hernandez-Rios, Sergio Duran-Barragan, Adriana Sanchez-Ortiz, Francisco Javier Aceves-Avila, Jose Dionisio Castillo-Ortiz, Oscar Gonzalez-Perez.   

Abstract

The aim of this study is to assess the trends in work disability and sick leave in ankylosing spondylitis (AS). In 1993 and 2007, patients diagnosed with AS that attended to a secondary- or a tertiary-care outpatient rheumatology clinics were evaluated for demographics, disease characteristics, axial mobility, working status, and work days missed due to sick leave or permanent disability. Factors that impacted labor status were identified by multiple regression analysis. In 1993, 91 study individuals (mean age 35 years, mean disease duration 10 ± 8 years) included 28 (31%) on permanent disability and 63 currently working; of these 63, 42 (67%) had missed at least 1 work day in the previous 12 months (mean 69 ± 63 days). In the next 5 years, the annual permanent disability was 3%. In 2007, 185 study individuals (mean age 42, mean disease duration 12 ± 10 years) included 53 (39%) on permanent disability and 132 active workers; 35 (66%) out of the 53 began permanent disability between 1999 and 2007 (2.1% annual disability rate), and 53 (40%) out of 132 active workers missed at least 1 work day in the previous 12 months (mean 52 ± 63 days). Only age predicted disability, with 10% and 11% increases in risk per year in 1993 and 2007, respectively (hazard ratios 1.09 and 1.11, respectively; p = 0.03 for both). Although the impact of AS on work seems to decrease slightly during the last 15 years, the actual impact is still substantial. An important proportion of patients went on permanent disability in the three decades before retirement. Extrapolating these results to official data for the year 2005, we may infer that between 1.3 million and nearly 15 million working days were missed that year due to AS.

Entities:  

Mesh:

Year:  2011        PMID: 21210289     DOI: 10.1007/s10067-010-1669-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis.

Authors:  Maria E Suarez-Almazor
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

2.  Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

Authors:  Wilfried Mau; Joachim Listing; Doerte Huscher; Henning Zeidler; Angela Zink
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

3.  Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis.

Authors:  S M M Verstappen; J W G Jacobs; D M van der Heijde; Sj van der Linden; C M Verhoef; J W J Bijlsma; A Boonen
Journal:  Ann Rheum Dis       Date:  2006-12-15       Impact factor: 19.103

4.  The outcome of ankylosing spondylitis: a study of 100 patients.

Authors:  J T Gran; J F Skomsvoll
Journal:  Br J Rheumatol       Date:  1997-07

5.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

Review 6.  The burden of ankylosing spondylitis.

Authors:  Annelies Boonen; Sjef M van der Linden
Journal:  J Rheumatol Suppl       Date:  2006-09

Review 7.  The epidemiology of ankylosing spondylitis.

Authors:  J T Gran; G Husby
Journal:  Semin Arthritis Rheum       Date:  1993-04       Impact factor: 5.532

8.  Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.

Authors:  T Y Zhu; L-S Tam; V W-Y Lee; W W Hwang; T K Li; K K Lee; E K Li
Journal:  Rheumatology (Oxford)       Date:  2008-07-17       Impact factor: 7.580

9.  Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic.

Authors:  S Forejtová; H Mann; J Stolfa; K Vedral; I Fenclová; D Némethová; K Pavelka
Journal:  Clin Rheumatol       Date:  2008-02-05       Impact factor: 2.980

Review 10.  A meta-analysis of observational studies identifies predictors of sickness absence.

Authors:  Saskia F A Duijts; Ijmert Kant; Gerard M H Swaen; Piet A van den Brandt; Maurice P A Zeegers
Journal:  J Clin Epidemiol       Date:  2007-08-23       Impact factor: 6.437

View more
  4 in total

1.  Diagnosis of Ankylosing Spondylitis: Do not let the spine bites the eye.

Authors:  Chia Chee Chew; Ju Juen Chin; Wan Hazabbah Wan Hitam; Mei Fong Chong; Liza-Sharmini Ahmad Tajudin
Journal:  Malays Fam Physician       Date:  2021-06-04

2.  Translation into Brazilian Portuguese, cross-cultural adaptation and validation of the Stanford presenteeism scale-6 and work instability scale for ankylosing spondylitis.

Authors:  Renata Frauendorf; Marcelo de Medeiros Pinheiro; Rozana Mesquita Ciconelli
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

3.  Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

Authors:  Tom Nadin; Dinny Wallis; Christopher R Holroyd; Stefania D'Angelo; Karen Walker-Bone; Christopher J Edwards
Journal:  BMC Musculoskelet Disord       Date:  2020-04-06       Impact factor: 2.362

4.  Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis.

Authors:  Joanna Shim; Gareth T Jones; Ejaz M I Pathan; Gary J Macfarlane
Journal:  Ann Rheum Dis       Date:  2018-08-03       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.